JB/PUT/MERCK & CO./115/0.0333/21.06.24 Share Price

Warrant

MRKEJB

CH1286510552

Real-time Bid/Ask 13:30:25 24/05/2024 BST
0.001 CHF / 0.011 CHF -45.45% Intraday chart for JB/PUT/MERCK & CO./115/0.0333/21.06.24
1 month-72.50%
3 months-81.67%

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying MERCK & CO., INC.
Issuer Bank Julius Bär
MRKEJB
ISINCH1286510552
Date issued 01/09/2023
Strike 115 $
Maturity 21/06/2024 (28 Days)
Parity 30 : 1
Emission price 0.33 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 0.5 CHF
Lowest since issue 0.011 CHF
Spread 0.01 CHF
Spread %90.91%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.1 USD
Average target price
141.9 USD
Spread / Average Target
+8.23%
Consensus
  1. Stock Market
  2. Warrants
  3. MRKEJB Warrant